MALIGNANT SOLID TUMORS
Clinical trials for MALIGNANT SOLID TUMORS explained in plain language.
Never miss a new study
Get alerted when new MALIGNANT SOLID TUMORS trials appear
Sign up with your email to follow new studies for MALIGNANT SOLID TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for leukemia patients when first treatment fails
Disease control Recruiting nowThis study is testing a drug called asciminib for adults with chronic myeloid leukemia (CML) when their first standard treatment has stopped working or caused intolerable side effects. The main goal is to see how well asciminib controls the leukemia by measuring a specific marker…
Matched conditions: MALIGNANT SOLID TUMORS
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New drug combo trial offers hope for advanced cancer patients
Disease control Recruiting nowThis study is testing whether a new drug called SHR-7787 works better when combined with other cancer medications for people with advanced solid tumors. Researchers will enroll 400 patients to check if the treatment is safe and if it helps shrink tumors or slow cancer growth. The…
Matched conditions: MALIGNANT SOLID TUMORS
Phase: PHASE2 • Sponsor: Shanghai Hengrui Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New cancer drug enters human testing for Tough-to-Treat tumors
Disease control Recruiting nowThis early-stage clinical trial is testing a new drug called SHR-1681 in patients with advanced solid tumors that have stopped responding to standard treatments. The study aims to find the safest and most effective dose, understand how the drug moves through the body, and see if …
Matched conditions: MALIGNANT SOLID TUMORS
Phase: PHASE1, PHASE2 • Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
New cancer drug combo enters Mid-Stage testing
Disease control Recruiting nowThis study is testing whether a new drug called SHR-4849, when combined with other cancer drugs, is safe and can help shrink tumors in people with advanced solid cancers. It will enroll about 120 adults with various cancers that have not responded to standard treatments. The main…
Matched conditions: MALIGNANT SOLID TUMORS
Phase: PHASE2 • Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Mar 05, 2026 13:59 UTC
-
Massive 10,000-Person hunt for clues to beat rare cancers
Knowledge-focused Recruiting nowThis study aims to learn more about rare cancers by collecting health information and biological samples from people who have them or are at risk. Researchers will follow 10,000 participants over time to understand how these rare tumors develop and behave. The goal is to use this…
Matched conditions: MALIGNANT SOLID TUMORS
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:30 UTC
-
Scientists test if new cancer scan gives same picture twice
Knowledge-focused Recruiting nowThis study aims to see if a new type of MRI scan gives consistent results when repeated. Researchers are testing the scan, which uses a special imaging agent, in people with solid tumors like breast, prostate, or brain cancer. The goal is to understand if this scan reliably shows…
Matched conditions: MALIGNANT SOLID TUMORS
Phase: NA • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:28 UTC